Opioid Addiction Harm Reduction: What to Know

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

SOURCES:

Addiction: “Rate of Detoxification Service Use and its Impact Among a Cohort of Supervised Injecting Facility Users.”

American Addiction Centers: “Suboxone Withdrawal: Symptoms, Timeline & Detox Treatment.”

Caleb Blaschke, Sioux Falls, SD.

Canadian Mental Health Association: “Harm Reduction.”

City of New York: “Overdose Prevention Centers Averted 59 Overdoses in First Three Weeks of Operation.”

Cleveland Clinic: “Is Naloxone (Narcan) Sold Over-the-Counter?”

Consumer Federation of America: “Traditional Savings Accounts: Are They Still Popular?”

Drug and Alcohol Dependence: “Socioeconomic Marginalization and Opioid-Related Overdose: A Systematic Review,” “Supervised Injection Services: What Has Been Demonstrated? A Systematic Literature Review.”

Eric R., Find Addiction Rehabs, Boca Raton, FL.

Federal Deposit Insurance Corporation: “How America Banks: Household Use of Banking and Financial Services.”

FXB Center for Health & Human Rights at Harvard University: “From the War on Drugs to Harm Reduction: Imagining a Just Overdose Crisis Response.”

Harm Reduction Journal: “Harm Reduction in the USA: The Research Perspective and an Archive to David Purchase.”

Health & Justice: “Pre-Arrest Diversion to Addiction Treatment by Law Enforcement: Protocol for the Community-Level Policing Initiative to Reduce Addiction-Related Harm, Including Crime.”

Hopkins Bloomberg Public Health: “5 Things to Know About Overdose Prevention Sites.”

International Journal of Drug Policy: “Barriers to Naloxone Use and Acceptance among Opioid Users, First Responders, and Emergency Department Providers in New Hampshire, USA.”

Journal of Addictive Disease: “Stigma from the Viewpoint of the Patient.”

Journal of Behavioral Health Services & Research: “Provider Views of Harm Reduction Versus Abstinence Policies Within Homeless Services for Dually Diagnosed Adults.”

Journal of Healthcare for the Poor and Underserved: “The Data Dilemma in Family Homelessness.”

The Lancet: “Reduction in Overdose Mortality after the Opening of North America’s First Medically Supervised Safer Injecting Facility: A Retrospective Population-Based Study.”

Letter signed by 14 U.S. Senators opposing supervised injections sites, sent to President Joseph R. Biden, Feb. 15, 2022.

NBC New York: “I-Team: Father Faults Judge for Son’s Heroin Overdose.”

The New York Times: “Nation’s First Supervised Drug-Injection Sites Open in New York.”

Social Science & Medicine: “Association between Homelessness and Opioid Overdose and Opioid-related Hospital Admissions/Emergency Department Visits.”

Substance Abuse and Mental Health Services Administration (SAMHSA): “Harm Reduction,” “Medication-Assisted Treatment (MAT),” “Naloxone.”

Washington State Department of Health: “Fentanyl Test Strip Project.”

The White House: “White House Releases Model Law to Help States Ensure Access to “Safe, Effective, and Cost-Saving” Syringe Services Programs.”

University of Southern California Department of Nursing: “Supervised Injection Sites are Coming to the United States: Here’s What You Should Know.”

U.S. Department of Health and Human Services: “Medication-Assisted Treatment for Opioid Addiction.”

U.S. Department of Housing and Urban Development: “Homelessness Increasing Even Prior to COVID-19 Pandemic.”

U.S. Government Accountability Office: “Drug Misuse: Most States Have Good Samaritan Laws and Research Indicates They May Have Positive Effects.”

Source: https://www.webmd.com/mental-health/addiction/features/opioid-addiction-harm-reduction?src=RSS_PUBLIC